# Cumberland Pharmaceuticals Inc: Form DEF 14A, filed Mar 13, 2024

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: DEF 14A
- Filed: 2024-03-13
- Accepted by EDGAR: Mar 13, 2024, 17:03 ET
- Period: 2023-12-31
- Accession: 0001628280-24-010960
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000162828024010960/a2023proxystatement.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000162828024010960/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000162828024010960/a2023proxystatement.htm

Filed Mar 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-010960. Last ingested by Listed: Oct 26, 2026, 16:41 ET. No prices; not investment advice.